Page 30 - Pfizer
Pfizer to buy Anacor in $5.2-bn deal
The net-of-cash deal value assumes conversion of Anacor's outstanding convertible notes
 "Pfizer to buy Anacor in $5.2-bn deal")
Pfizer to acquire Anacor Pharmaceuticals for $5.2 bn
Anacor's flagship asset, crisaborole, is currently under review by the USFDA for the treatment of mild-to-moderate atopic dermatitis, commonly referred to as eczema
 "Pfizer to acquire Anacor Pharmaceuticals for $5.2 bn")
Pfizer restricts sale of its drugs used in executions
With this all 25 companies that produce medicines used in executions have blocked their sale for that purpose
Pfizer approaches Medivation about potential take-over
Medivation has not yet decided whether it should engage with Pfizer in negotiations and is in discussions with its financial and legal advisers
Pfizer needs Plan C after Allergan fallout
Pfizer's $152-billion merger with Allergan failed after the Obama administration introduced rules that would make the deal much less attractive
 "Pfizer needs Plan C after Allergan fallout")
Pfizer to end its $160-bn Allergan deal
Move comes in as a major victory to US President Barack Obama's drive to stop tax-dodging corporate mergers
 "Pfizer to end its $160-bn Allergan deal")
Obama's inversion curbs kill Pfizer's $160-bn Allergan deal
The decision by Obama administration to end the biggest tax 'inversion' ever attempted would otherwise have seen Pfizer slash its tax bill by redomiciling to Ireland where Allergan is registered
Pfizer, P&G stock down by up to 3% on drug ban
Pfizer stopped sale of cough syrups Corex and Phensedyl after govt banned over 300 fixed dose combination drugs
 "Pfizer, P&G stock down by up to 3% on drug ban")
Delhi High Court grants Pfizer temporary relief on cough syrup ban
The court said the government had not issued Pfizer a 'show cause notice' before banning the medicine
Banning cough syrups will hit Pfizer most
Its brand Corex is a big contributor to revenues, but measure may reduce earnings estimate for firm
 "Banning cough syrups will hit Pfizer most")
Delhi High Court grants interim; restrains sale of Corex syrup
Sale of over 300 drugs' combination have been banned; HC granted relief saying they've been in business for 25 years
Pfizer dips after ban on Corex cough syrup in India
The stock dipped 5% to Rs 1,827 on the BSE.
 "Pfizer dips after ban on Corex cough syrup in India")
Pfizer stops selling popular Corex cough syrup in India after ban
India has banned over 344 drug combinations after a govt panel of experts found that they had no therapeutic justification
Pfizer to get patent for cholesterol lowering formulation
Global pharma giant Pfizer Inc has received a patent for invention to address the issues related to cholesterol and related disease including cardiovascular disease. The Indian Patent Office has said that the company amended its set of claims for the invention titled PCSK9 Antagonists and there were no technical and formal objections pending, and the patent application shall proceed to grant patent. The invenGlobal pharma giant Pfizer Inc has received a patent for invention to address the issues related to cholesterol and related disease including cardiovascular tion, according to the company's application, is related to therapeutic methods for use of certain antibodies and antigen-binding portions to reduce LDL-cholesterol levels and for the treatment and prevention of cardiovascular disease, including treatment of hypercholesterolemia, a situation in which the cholesterol in blood is high. The company has a PCSK9 inhibitor, under the name bococizumab/RN316, in its pipeline to be ...
